Cargando…
Mitochondrial bioenergetics in ocular fibroblasts of two myasthenia gravis cases
Myasthenia gravis (MG) is a rare, treatable, antibody-mediated disease characterized by fatigable muscle weakness of extraocular muscles (EOMs) and non-ocular skeletal muscles. The antibodies are directed against muscle-endplate proteins, most frequently the acetylcholine receptor (AChR) alpha-subun...
Autores principales: | Europa, Tarin A., Nel, Melissa, Lebeko, Maribanyana R., Heckmann, Jeannine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210483/ https://www.ncbi.nlm.nih.gov/pubmed/35746973 http://dx.doi.org/10.1016/j.ibneur.2022.04.007 |
Ejemplares similares
-
The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review
por: Heckmann, Jeannine M., et al.
Publicado: (2022) -
Gene expression profiling of orbital muscles in treatment-resistant ophthalmoplegic myasthenia gravis
por: Europa, Tarin A., et al.
Publicado: (2020) -
Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review
por: Aly, Esraa, et al.
Publicado: (2021) -
Selenium reduces nociceptive response in acute 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced neurotoxicity
por: Abolarin, Patrick Oluwole, et al.
Publicado: (2021) -
Transcutaneous electrical nerve stimulation in the management of calf muscle spasticity in cerebral palsy: A pilot study
por: Logosu, Delali, et al.
Publicado: (2021)